Evidence map›Paper›PMID 35624601›Full record

ArticleBiosensors2022

Label-Free Detection of the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein at Physiologically Relevant Concentrations Using Surface-Enhanced Raman Spectroscopy.

Andrey K Sarychev, Alyona Sukhanova, Andrey V Ivanov, Igor V Bykov, Nikita V Bakholdin, Daria V Vasina, Vladimir A Gushchin, Artem P Tkachuk, Galina Nifontova, Pavel S Samokhvalov and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 21 citations in OpenAlex.

  1. Functionalized Optical Microcavities for Sensing Applications.Nanomaterials (Basel, Switzerland) · 2025
    Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Andrey K SarychevInstitute of Theoretical and Applied Electrodynamics, Russian Academy of Sciences, 125412 Moscow, Russia.ORCID 0000-0002-2096-6318
Alyona SukhanovaLaboratoire de Recherche en Nanosciences, LRN-EA4682, Université de Reims Champagne-Ardenne, 51100 Reims, France.ORCID 0000-0003-2796-7898
Andrey V IvanovInstitute of Theoretical and Applied Electrodynamics, Russian Academy of Sciences, 125412 Moscow, Russia.
Igor V BykovInstitute of Theoretical and Applied Electrodynamics, Russian Academy of Sciences, 125412 Moscow, Russia.
Nikita V BakholdinMoscow Power Engineering Institute, National Research University, 111250 Moscow, Russia.ORCID 0000-0003-3341-3074
Daria V VasinaGamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia.ORCID 0000-0003-1965-0700
Vladimir A GushchinGamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia.
Artem P TkachukGamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia.
Galina NifontovaLaboratoire de Recherche en Nanosciences, LRN-EA4682, Université de Reims Champagne-Ardenne, 51100 Reims, France.ORCID 0000-0002-6956-5654
Pavel S SamokhvalovMoscow Engineering Physics Institute, National Research Nuclear University MEPhI, 115409 Moscow, Russia.ORCID 0000-0002-2878-8376
Alexander KaraulovDepartment of Clinical Immunology and Allergology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University (Sechenov University), 119146 Moscow, Russia.ORCID 0000-0002-1930-5424
Igor NabievLaboratoire de Recherche en Nanosciences, LRN-EA4682, Université de Reims Champagne-Ardenne, 51100 Reims, France.ORCID 0000-0002-8391-040X
Institute of Theoretical and Applied Electrodynamics · RULaboratoire de Recherche en NanosciencesMinistry of Health of the Russian Federation · RUSechenov University · RULomonosov Moscow State University · RUMoscow Power Engineering Institute · RUNational Research Nuclear University MEPhI · RU

Funding

Russian Foundation for Basic Research 20-04-60440Russian Foundation for Basic Research 20-21-00080Russian Science Foundation 21-79-30048
6 · The paper itself

Abstract

Surface-enhanced Raman scattering (SERS) spectroscopy is a surface- or cavity-enhanced variant of Raman scattering spectroscopy that allows the detection of analytes with a sensitivity down to single molecules. This method involves the use of SERS-active surfaces or cavities capable of concentrating incident radiation into small mode volumes containing the analyte. Here, we have engineered an ultranarrow metal-dielectric nano-cavity out of a film of the receptor-binding domain (RBD) of SARS-CoV-2 spike (S) glycoprotein and a silver surface, held together by interaction between reduced protein sulfhydryl groups and silver. The concentration of light in this nano-cavity allows the label-free recording of the characteristic Raman spectra of protein samples smaller than 1 pg. This is sufficient for the ultrasensitive detection of viral protein antigens at physiologically relevant levels. Moreover, the protein SERS signal can be increased by several orders of magnitude by coating the RBD film with a nanometer-thick silver shell, thereby raising the cavity Q-factor. This ensures a sub-femtogram sensitivity of the viral antigen detection. A simple theoretical model explaining the observed additional enhancement of the SERS signal from the silver-coated protein is proposed. Our study is the first to obtain the characteristic Raman and SERS spectra of the RBD of S glycoprotein, the key SARS-CoV-2 viral antigen, directly, without the use of Raman-reporter molecules. Thus, our approach allows label-free recording of the characteristic spectra of viral antigens at concentrations orders of magnitude lower than those required for detecting the whole virus in biological media. This makes it possible to develop a high-performance optical detection method and conformational analysis of the pathogen and its variants.

Indexed as

COVID-19Spectrum Analysis, RamanAntigens, ViralHumansSARS-CoV-2SilverSpike Glycoprotein, CoronavirusAntigens, ViralSilverSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2AFMRaman spectroscopyRBDSARS-CoV-2SERSS glycoproteinsurface-enhanced Raman spectroscopy

Identifiers

PMID35624601
PMCPMC9138710
OpenAlexW4280634576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.